Total Funding: $720.7M
Headquarters: San Diego, California, United States
Funding Status: IPO
Employee Number: 51-100
Estimated Revenue: $50M to $100M
Last Funding Type: Post-IPO Equity
Technology: Anti-infective Drugs
Investor Type: For Profit
Investors Number: 11
Founded Date: 2013
Industry: PharmTech